DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 124 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2017. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $107,000 | -23.6% | 12,150 | -20.6% | 0.10% | -54.2% |
| Q4 2018 | $140,000 | -20.9% | 15,300 | +7.0% | 0.22% | -2.2% |
| Q3 2018 | $177,000 | -18.8% | 14,300 | 0.0% | 0.23% | -26.3% |
| Q2 2018 | $218,000 | -23.0% | 14,300 | 0.0% | 0.31% | -19.2% |
| Q1 2018 | $283,000 | +14.1% | 14,300 | +7.5% | 0.39% | -1.5% |
| Q4 2017 | $248,000 | +6.0% | 13,300 | +22.0% | 0.39% | -20.3% |
| Q3 2017 | $234,000 | +88.7% | 10,900 | -15.5% | 0.49% | +105.9% |
| Q2 2017 | $124,000 | – | 12,900 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |